C07D 317/48
Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
C07D317/48 (Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring) appears on 2,318 US grants and 1,743 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,318
- Published applications
- 1,743
- Assignees
- 1,062
- Inventors
- 7,026
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 65 | 0 |
| 1977 | 40 | 0 |
| 1978 | 33 | 0 |
| 1979 | 40 | 0 |
| 1980 | 48 | 0 |
| 1981 | 39 | 0 |
| 1982 | 34 | 0 |
| 1983 | 25 | 0 |
| 1984 | 19 | 0 |
| 1985 | 30 | 0 |
| 1986 | 19 | 0 |
| 1987 | 38 | 0 |
| 1988 | 30 | 0 |
| 1989 | 33 | 0 |
| 1990 | 46 | 0 |
| 1991 | 44 | 0 |
| 1992 | 30 | 0 |
| 1993 | 44 | 0 |
| 1994 | 33 | 0 |
| 1995 | 35 | 0 |
| 1996 | 42 | 0 |
| 1997 | 42 | 0 |
| 1998 | 65 | 0 |
| 1999 | 52 | 0 |
| 2000 | 59 | 0 |
| 2001 | 79 | 17 |
| 2002 | 94 | 68 |
| 2003 | 66 | 101 |
| 2004 | 62 | 122 |
| 2005 | 53 | 108 |
| 2006 | 63 | 101 |
| 2007 | 53 | 95 |
| 2008 | 48 | 88 |
| 2009 | 77 | 85 |
| 2010 | 64 | 92 |
| 2011 | 57 | 80 |
| 2012 | 56 | 64 |
| 2013 | 64 | 58 |
| 2014 | 69 | 74 |
| 2015 | 51 | 66 |
| 2016 | 49 | 50 |
| 2017 | 38 | 45 |
| 2018 | 36 | 50 |
| 2019 | 50 | 38 |
| 2020 | 31 | 56 |
| 2021 | 36 | 41 |
| 2022 | 34 | 41 |
| 2023 | 20 | 56 |
| 2024 | 32 | 67 |
| 2025 | 35 | 45 |
| 2026 | 16 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for the preparation of 3,4-methylenedioxypropiophenone6 Oct 2026US 12,753,160 B2Endura S. P. A.
- Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and N-methyl-1,3-benzodioxolylbutanamine (MBDB)14 Jul 2026US 12,679,817 B2Pharmala Biotech Inc.
- Secondary battery and vehicle including secondary battery16 Jun 2026US 12,658,478 B2Semiconductor Energy Laboratory Co.Ltd.
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- Arylamides and methods of use thereof19 May 2026US 12,630,498 B2Genzyme Corporation
- Trpv1 agonist and uses thereof17 Sep 2026US 2026/0274802 A1SciTherm Therapeutics Corporation
- 3-[(benzo[d][1,3]dioxolane-4-yl)oxy]propylamine hydrochloride, optical isomer and crystal thereof, and preparation method therefor3 Sep 2026US 2026/0258009 A1Jiangsu Nhwa Pharmaceutical Co., Ltd
- Inhibitors of bacterial type iii secretion system27 Aug 2026US 2026/0248774 A1Microbiotix, Inc.
- Highly atom economical process for synthesis of novel co-initiator for photo-induced radical polymerisation20 Aug 2026US 2026/0242348 A1SHIV NADAR (Institution of Eminence Deemed To Be University)
- Nematicidal compounds, their composition and use thereof13 Aug 2026US 2026/0231945 A1
Most cited
By later US patents
- Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof1,998US 5,143,854 AAffymax Technologies N.V. · 1992
- Array of oligonucleotides on a solid substrate1,585US 5,445,934 AAffymax Technologies N.V. · 1995
- Arrays of materials attached to a substrate1,410US 5,744,305 AAffymetrix, Inc. · 1998
- Very large scale immobilized polymer synthesis967US 5,424,186 AAffymax Technologies N.V. · 1995
- Method of detecting nucleic acids962US 5,800,992 A1998